Publications by authors named "S Orloff"
Article Synopsis
- Hepatitis C virus-related liver cancer affects minorities in the U.S. the hardest due to socioeconomic barriers, prompting a study on treatment outcomes among different racial and ethnic groups.
- A study of 666 patients who completed antiviral therapy and underwent liver transplantation found no significant differences in 5-year recurrence-free survival or overall survival among White, Black, Hispanic, and Other racial/ethnic groups.
- The findings indicate that when treatment barriers are removed, race/ethnicity does not impact cancer outcomes, highlighting the need to prioritize eliminating access obstacles for minority populations.
Importance: A new liver allocation policy was implemented by United Network for Organ Sharing (UNOS) in February 2020 with the stated intent of improving access to liver transplant (LT). There are growing concerns nationally regarding the implications this new system may have on LT costs, as well as access to a chance for LT, which have not been captured at a multicenter level.
Objective: To characterize LT volume and cost changes across the US and within specific center groups and demographics after the policy implementation.